Genetic Technologies Ltd.
GENE
GENE was delisted on the 16th of October, 2024.
11 hedge funds and large institutions have $342K invested in Genetic Technologies Ltd. in 2018 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
21% less funds holding
Funds holding: 14 → 11 (-3)
54% less capital invested
Capital invested by funds: $743K → $342K (-$400K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$116K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$23.2K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$2.86K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$177K |
| 2 |
Jane Street
New York
|
-$15K |
| 3 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$3K |
| 4 |
BA
Ballew Advisors
Jackson,
Mississippi
|
-$2K |
| 5 |
CG
Cutler Group
San Francisco,
California
|
-$103 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $227K | -$177K | -8,548 | -29% |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $82K | +$116K | +5,607 | +280% |
|
|
3
Citadel Advisors
Miami,
Florida
| $18K | +$23.2K | +1,120 | +194% |
|
4
Cambridge Investment Research Advisors
Fairfield,
Iowa
| $9K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $3K | +$2.86K | +138 | +212% |
|
|
CG
6
Cutler Group
San Francisco,
California
| $2K | -$103 | -5 | -2% |
|
7
Morgan Stanley
New York
| $1K | – | – | – |
|
|
FDCDDQ
8
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $246 | – | – | – |
|
|
RE
9
RBC Europe
London,
United Kingdom
| $44 | – | – | – |
|
|
10
Jane Street
New York
| – | -$15K | -677 | Closed |
|
|
LTFS
11
Ladenburg Thalmann Financial Services
Miami,
Florida
| – | -$3K | -138 | Closed |
|
|
BA
12
Ballew Advisors
Jackson,
Mississippi
| – | -$2K | -95 | Closed |
|
GENE Hedge Fund Activity: Q4 2018 in Review
11 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q4 2018, worth a combined $342K — down 54% from $743K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of GENE and 0 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 3 added.
The largest buyer was Susquehanna International Group, adding an estimated $116K. The largest seller was Renaissance Technologies, cutting an estimated $177K.
- 11 institutional investors held Genetic Technologies Ltd. (GENE) as of Q4 2018, down from 14 in Q3 2018.
- Funds reported $342K of Genetic Technologies Ltd. stock for Q4 2018, down 54% quarter-over-quarter.
- 0 funds opened new Genetic Technologies Ltd. positions in Q4 2018 and 3 closed out, a net change of -3 holders.
- The largest Genetic Technologies Ltd. buyer in Q4 2018 was Susquehanna International Group, an estimated $116K added.
- The largest Genetic Technologies Ltd. seller in Q4 2018 was Renaissance Technologies, an estimated $177K sold.
Based on aggregated 13F filings for Q4 2018.